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Introduction {#embj201695335-sec-0001}
============

Polycomb group proteins (PcG) are highly conserved factors that mainly act in the context of multi‐subunit nuclear complexes to maintain transcriptional repression. Their disruption interferes with various processes, ranging from genomic imprinting to cell identity and differentiation. The functions of PcG proteins rely on the regulation of chromatin structure, either through histone modifications or through chromatin compaction (Simon & Kingston, [2009](#embj201695335-bib-0042){ref-type="ref"}). In *Drosophila*, four PcG complexes have been identified, while in mammals, only two complexes are well characterized so far: Polycomb Repressive Complex 2 (PRC2) and Polycomb Repressive Complex 1 (PRC1). The PRC2 is responsible for histone H3 lysine 27 (H3K27) di‐ and tri‐methylation (Margueron & Reinberg, [2011](#embj201695335-bib-0028){ref-type="ref"}).

Although our understanding of how PRC2 contacts chromatin has improved, how it is specifically recruited to defined genomic loci is still only partially understood. The core PRC2 has no known sequence‐specific DNA‐binding domain. In *Drosophila,* DNA sequences known as Polycomb responsive elements (PREs) mediate PcG recruitment through a combination of specific transcription factors. Although similar mechanisms have been proposed in mammals (Arnold *et al*, [2013](#embj201695335-bib-0001){ref-type="ref"}; Sing *et al*, [2009](#embj201695335-bib-0043){ref-type="ref"}; Woo *et al*, [2010](#embj201695335-bib-0049){ref-type="ref"}), they do not appear to be the general rule. Indeed, the specific transcription factors found to bind these putative mammalian PREs do not act consistently as PRC2 genomewide recruiters. Importantly, GC‐rich regions are frequently bound by PRC2 components (Ku *et al*, [2008](#embj201695335-bib-0024){ref-type="ref"}) and they are, in some instances, sufficient to mediate PRC2 recruitment (Mendenhall *et al*, [2010](#embj201695335-bib-0030){ref-type="ref"}; Jermann *et al*, [2014](#embj201695335-bib-0016){ref-type="ref"}), although once again this cannot account for the specificity and dynamics of Polycomb recruitment in diverse developmental contexts.

It has been long known that RNAs carry out many functions independent of their protein‐coding potential (Cech & Steitz, [2014](#embj201695335-bib-0005){ref-type="ref"}). Non‐coding RNAs are divided into various subclasses, one of which comprises the lncRNAs. LncRNAs are defined as RNA molecules longer than 200 nucleotides that are transcribed by RNA polymerase II, capped, spliced, and polyadenylated. Hence, with the exception of their lack of coding potential, lncRNAs fully resemble messenger RNAs. Many cellular functions have been ascribed to lncRNAs, although genetic inactivation has not always substantiated the initial observations (Rutenberg‐Schoenberg *et al*, [2016](#embj201695335-bib-0037){ref-type="ref"}). Nonetheless, several lncRNAs are reported to influence transcription in the nucleus, in particular through the regulation of chromatin modifiers (Schmitz *et al*, [2016](#embj201695335-bib-0039){ref-type="ref"}). The variety of lncRNAs and their tissue‐specific patterns of expression point toward potential functions in development.

Maybe not surprisingly, lncRNAs have been proposed to play an important role in the recruitment of PRC2 to specific chromatin regions, both in *cis* and in *trans* (Koziol & Rinn, [2010](#embj201695335-bib-0023){ref-type="ref"}). The best‐studied example of lncRNA‐dependent *cis‐*targeting of chromatin modifiers is the localization of PRC2 to the inactive chromosome X (Xi), downstream of Xist RNA (Plath *et al*, [2003](#embj201695335-bib-0032){ref-type="ref"}). A direct interaction between PRC2 and the conserved Xist A‐repeat region has been suggested to mediate this effect (Zhao *et al*, [2008](#embj201695335-bib-0050){ref-type="ref"}). However, H3K27me3 deposition is still induced when Xist RNA is deleted for the A‐repeats (Kohlmaier *et al*, [2004](#embj201695335-bib-0022){ref-type="ref"}; da Rocha *et al*, [2014](#embj201695335-bib-0036){ref-type="ref"}), and recent studies aimed at characterizing the Xist interactome did not retrieve factors unambiguously linked to PRC2 (Chu *et al*, [2015](#embj201695335-bib-0007){ref-type="ref"}; McHugh *et al*, [2015](#embj201695335-bib-0029){ref-type="ref"}; Minajigi *et al*, [2015](#embj201695335-bib-0031){ref-type="ref"}). While other domains of Xist could be involved in PRC2 targeting (da Rocha *et al*, [2014](#embj201695335-bib-0036){ref-type="ref"}), direct physical interaction between Xist and PRC2 still remains to be proven. Importantly, PRC2 is not required for establishement of transcriptional silencing of the future inactive X; instead, it prevents aberant gene re‐activation in specific tissues (Kalantry *et al*, [2006](#embj201695335-bib-0017){ref-type="ref"}).

The best‐known example of PRC2 targeting in *trans* by a lncRNA comes from the HOX antisense intergenic RNA *HOTAIR*. This is a 2,148‐nucleotide‐long RNA, originating from the *HOXC* locus, that has been reported to be necessary to target PRC2 in *trans* to the *HOXD* locus and additional genomic loci (Rinn *et al*, [2007](#embj201695335-bib-0034){ref-type="ref"}; Chu *et al*, [2011](#embj201695335-bib-0006){ref-type="ref"}). *HOTAIR* RNA adopts a defined secondary structure at its 5′ end, which is proposed to be critical for its interaction with the PRC2 *in vitro* (Tsai *et al*, [2010](#embj201695335-bib-0046){ref-type="ref"}; Somarowthu *et al*, [2015](#embj201695335-bib-0045){ref-type="ref"}). *HOTAIR* RNA also interacts with another repressive chromatin modifier, the LSD1/coREST/REST complex that catalyzes H3K4me2 demethylation. Hence, it has been proposed to act as a scaffold to coordinate recruitment of both the PRC2 and LSD1/coREST/REST complexes onto chromatin (Tsai *et al*, [2010](#embj201695335-bib-0046){ref-type="ref"}). However, in mice, genetic deletion of the entire *HOXC* cluster (including *HOTAIR*) does not seem to impair H3K27me3 at the *HOXD* locus in any major way (Schorderet & Duboule, [2011](#embj201695335-bib-0040){ref-type="ref"}). On the other hand, a more localized deletion of several kb including *HOTAIR* is reported to do so (Li *et al*, [2013](#embj201695335-bib-0027){ref-type="ref"}). Deregulation of *HOTAIR* has also been observed in cancer cells (Gupta *et al*, [2010](#embj201695335-bib-0015){ref-type="ref"}). Overexpression studies performed in a cell line model of triple‐negative breast cancer have linked elevated *HOTAIR* levels to a re‐targeting of PRC2 to several hundred genes, and it has been proposed that *HOTAIR* deregulation might contribute to tumor progression (Gupta *et al*, [2010](#embj201695335-bib-0015){ref-type="ref"}).

Given the defined interaction suggested to occur between PRC2 and *HOTAIR*, it is surprising to note that *in vitro* and *in vivo* studies investigating the interplay between PRC2 and lncRNAs have reported a rather promiscuous binding of PRC2 and its cofactor JARID2 to RNA (Davidovich *et al*, [2013](#embj201695335-bib-0010){ref-type="ref"}; Kaneko *et al*, [2013](#embj201695335-bib-0018){ref-type="ref"}, [2014](#embj201695335-bib-0019){ref-type="ref"}; Beltran *et al*, [2016](#embj201695335-bib-0002){ref-type="ref"}). Altogether, the functional specificity of this interaction remains highly debated in the field (Brockdorff, [2013](#embj201695335-bib-0003){ref-type="ref"}).

In the present study, we set out to further investigate the link between lncRNAs and PRC2 using *HOTAIR* as paradigm. To this end, we first evaluated the transcriptomic consequences of *HOTAIR* overexpression in breast cancer cells in the context of a functional or inactivated PRC2. The lack of substantial changes prompted us to study the role of *HOTAIR* at a local level in model cell lines enabling artificial tethering of *HOTAIR* at a reporter transgene. Our study provides evidence that *HOTAIR* RNA can indeed repress transcription in this context, but that this local effect is PRC2 independent.

Results {#embj201695335-sec-0002}
=======

Overexpression of *HOTAIR* RNA leads to subtle, PRC2‐independent transcriptional changes in the MDA‐MB‐231 breast cancer cell line {#embj201695335-sec-0003}
----------------------------------------------------------------------------------------------------------------------------------

To investigate the link between *HOTAIR* RNA and PRC2, we took advantage of an MDA‐MD‐231 breast cancer cell line in which we had knocked out *EZH2* by genome editing (Wassef *et al*, [2015](#embj201695335-bib-0048){ref-type="ref"}). *HOTAIR* RNA overexpression was previously reported to lead to the transcriptional repression of hundreds of genes in the same model, presumably in *trans* (Gupta *et al*, [2010](#embj201695335-bib-0015){ref-type="ref"}). We overexpressed *HOTAIR* RNA in MDA‐MB‐231 EZH2+++ (wild‐type, original cell pool), MDA‐MB‐231 EZH2++− (clone with one *EZH2* allele targeted, behaving as wild type), and MDA‐MB‐231 EZH2−−− breast cancer cells (subclone derived from the MDA‐MB‐231 EZH2++−, Fig [1](#embj201695335-fig-0001){ref-type="fig"}A upper and lower panels). Transcript quantification by qRT--PCR revealed that *HOTAIR* RNA is expressed at similar levels in all three conditions (Fig [1](#embj201695335-fig-0001){ref-type="fig"}A) and that its level of overexpression is comparable to a previous study (Gupta *et al*, [2010](#embj201695335-bib-0015){ref-type="ref"}). As expected, overexpression of *HOTAIR* RNA has no effect on H3K27me3 global level (Fig [1](#embj201695335-fig-0001){ref-type="fig"}A) and we did not detect any obvious change of cellular phenotypes such as cell proliferation (Fig [EV1](#embj201695335-fig-0001ev){ref-type="fig"}A). To get a global picture of *HOTAIR*‐mediated transcriptional regulation and of the contribution of PRC2 to this process, we performed RNA sequencing on MDA‐MB‐231 EZH2++− and MDA‐MB‐231 EZH2−−− cell types, both in the control condition and upon overexpression of *HOTAIR* RNA. We obtained good correlation between replicates as shown by the Pearson correlation value matrix ([Appendix Table S1](#embj201695335-sup-0001){ref-type="supplementary-material"} and Fig [EV1](#embj201695335-fig-0001ev){ref-type="fig"}B). We subsequently focused on transcripts displaying the highest dispersion (higher interquartile) across the four conditions. Heatmap representing relative gene expression revealed that the two main clusters of differentially expressed genes are defined by *EZH2* mutation and not by *HOTAIR* RNA overexpression (Fig [1](#embj201695335-fig-0001){ref-type="fig"}A). In fact, we observed very similar correlation levels between duplicates and upon overexpression of *HOTAIR* (Fig [EV1](#embj201695335-fig-0001ev){ref-type="fig"}B). Nonetheless, we selected transcripts that were differentially expressed upon overexpression of *HOTAIR* RNA with an absolute expression fold change superior to 2 and a *P*‐value lower than 0.05. Within these criteria, very few transcripts were differentially expressed and most of them were upregulated regardless of whether PRC2 was functional or deficient (red dots on volcano plot, Figs [1](#embj201695335-fig-0001){ref-type="fig"}C and [EV1](#embj201695335-fig-0001ev){ref-type="fig"}C). In addition, close examination of this set of genes revealed that they are characterized by a very low read count (red dots, Fig [1](#embj201695335-fig-0001){ref-type="fig"}D). Of note, transcripts of genes that were previously reported to gain H3K27me3 upon overexpression of *HOTAIR* RNA (Gupta *et al*, [2010](#embj201695335-bib-0015){ref-type="ref"}) or that are located within 100 kb of its binding sites identified by ChIRP (Chu *et al*, [2011](#embj201695335-bib-0006){ref-type="ref"}) revealed a similar trend (Fig [EV1](#embj201695335-fig-0001ev){ref-type="fig"}D).

![Limited transcriptomic changes upon *HOTAIR* RNA overexpression in MDA‐MB‐231 breast cancer cells\
Western blot analysis of nuclear extracts from indicated cell lines with antibodies for EZH2 and H3K27m2/3 mark. Lamin B1 and H3 are shown as loading controls (upper panel). qRT--PCR to test *HOTAIR* overexpression in the corresponding cell lines. *Y*‐axis represents *HOTAIR* expression relative to U1 RNA (individual experiments and mean, *n* = 2) (lower panel).Heatmap showing expression intensity of the 1,000 genes with the higher interquartile range. Genes up‐ or downregulated from MDA‐MB‐231 EZH2++− and MDA‐MB‐231 EZH2−−− with (+*HOTAIR*) or without *HOTAIR* samples are shown. Red indicates high expression, and green indicates low expression.Volcano plots representing gene expression change upon overexpression of *HOTAIR* in MDA‐MB‐231 EZH2++−, or MDA‐MB‐231 EZH2−−− (*y*‐axis: log~10~ *P*‐value, *x*‐axis: log~2~ fold change). Red dots represent genes whose expression changes by more than twofold with a *P*‐value \< 0.05. *P*‐values: moderated *t*‐statistics.Left panel: Gene expression correlation between cells overexpressing *HOTAIR* or not. Expression is quantified as FPKM; red dots are differentially expressed genes (DEG). Right panel: Average FPKM for non‐DEG genes (\> 1 FPKM in at least one of the four conditions) or DEG as defined in (C).\
Source data are available online for this figure.](EMBJ-36-981-g002){#embj201695335-fig-0001}

![*HOTAIR* overexpression has marginal phenotypic and transcriptomic consequences on MDA‐MB‐231\
Proliferation assays in two different cell culture conditions. Cells were counted with an automatic cell counter at the time indicated on the plot (individual experiments and mean, *n* = 2).Pearson correlation matrix between each single‐sequenced sample. Value varies between 1 and 0.85.Number of differentially expressed genes depending on cutoff parameter.Volcano plots representing gene expression change upon overexpression of *HOTAIR* in MDA‐MB‐231 EZH2++− and focusing on genes either previously reported to gain H3K27me3 upon overexpression of *HOTAIR* (left panel) or to be located with 100 kb of a binding sites for *HOTAIR* (right panel) (*y*‐axis: log~10~ *P*‐value, *x*‐axis: log~2~ fold change). Red dots represent genes whose expression changes by more than twofold with a *P*‐value \< 0.05.\
Source data are available online for this figure.](EMBJ-36-981-g003){#embj201695335-fig-0001ev}

Altogether, these experiments suggest that *HOTAIR* RNA overexpression only marginally affects gene expression in the MDA‐MB‐231 breast cancer cell line and that this function does not critically require PRC2.

*In vivo* tethering of *HOTAIR* RNA induces gene silencing {#embj201695335-sec-0004}
----------------------------------------------------------

The lack of a substantial effect of *HOTAIR* overexpression on gene expression profiles prompted us to develop a method to assess whether *HOTAIR* could have a more local impact on transcription. To this end, we set up an RNA‐tethering system to force the recruitment of *HOTAIR* at a reporter transgene.

This system exploits two well‐known heterologous tools: the bacteriophage MS2 coat protein (MS2BP), which binds to the MS2 stem loop RNA (MS2 loop), and the UAS/Gal4 tethering system. Both systems have been successfully used in eukaryotic cells, the former to tether MS2BP‐fused proteins to MS2 loop hybrid RNAs (Keryer‐Bibens *et al*, [2008](#embj201695335-bib-0020){ref-type="ref"}) and the latter to target transcription factors or chromatin modifiers. The parental cell line (labeled 1) is T‐Rex HEK293 stably transfected with a luciferase reporter gene, the expression of which is controlled by the *tk* minimal promoter. UAS/Gal4‐binding sites enable the recruitment of a Gal4‐DNA binding domain fused to a protein of interest (Fig [2](#embj201695335-fig-0002){ref-type="fig"}A). We derived a subclone constitutively expressing a Gal4‐DNA binding domain MS2 coat‐protein fusion protein (labeled 2). From this clone, we subsequently derived cells expressing either *MS2 loop‐HOTAIR* (labeled 3) or *MS2 loop‐HOTAIR‐Rev* (RNA antisense to *HOTAIR*, labeled 4) hybrid RNAs (Fig [2](#embj201695335-fig-0002){ref-type="fig"}A). We checked the expression of the fused Gal4‐MS2BP protein by Western blot (Fig [EV2](#embj201695335-fig-0002ev){ref-type="fig"}A). Both *MS2‐HOTAIR* RNAs were expressed at similar levels (Fig [EV2](#embj201695335-fig-0002ev){ref-type="fig"}B). We confirmed the recruitment of Gal4‐MS2BP to the transgene by performing chromatin immunoprecipitation (Wang *et al*, [2005](#embj201695335-bib-0047){ref-type="ref"}), using an antibody recognizing the Gal4‐binding domain (Fig [2](#embj201695335-fig-0002){ref-type="fig"}B). RNA immunoprecipitation (RIP) with the same antibody further indicated that the fusion protein indeed interacts with the *MS2‐HOTAIR* or *MS2‐HOTAIR‐Rev* RNAs (Fig [2](#embj201695335-fig-0002){ref-type="fig"}C).

![*MS2‐HOTAIR* RNA causes repression when tethered to the luciferase transgene\
Schematic representation of the RNA‐tethering system to chromatin. *LUC A*,*LUC D* and *LUC E* indicate primer sets along the luciferase transgene used for ChIP qPCR. Each cell model is labeled by a number which is used in all figure legends hereafter.ChIP experiments with Gal4 antibody in the cell lines indicated on the *x*‐axis. *Y*‐axis represents percent of input (mean ± SD, *n* = 3).RIP experiments with Gal4 antibody in the cell lines indicated on the *x*‐axis. MS2 loop and U1 primers were used in qRT--PCR. *Y*‐axis represents fold enrichment to IgG (individual experiments and mean, *n* = 2). Input (In) and IP were loaded and probed with Gal4 antibody (lower panel).Relative luciferase activity in the cell lines indicated on the *x*‐axis. Values represent the relative luciferase activity normalized to the amount of protein (mean ± SD, *n* = 4). Statistical analysis: unpaired *t*‐test, \*\*\**P* \< 0.001.Upper panel: Relative luciferase activity in the cell lines indicated in the right legend (mean ± SD, *n* = 4). Statistical analysis: unpaired *t*‐test, \*\*\**P* \< 0.001. Cells were infected either with scramble (scr) or shRNA targeting Gal4‐MS2BP (shGAL4). Lower panel: Western blot analysis with anti‐Gal4 antibody in the different cell models; SUZ12 was used as a loading control.Upper panel: Relative luciferase activity in the cell lines indicated in the right legend (mean ± SD, *n* ≥ 2). Lower panel: qRT--PCR to detect *MS2‐HOTAIR* RNA in the cell models indicated in the right legend. *Y*‐axis represents MS2 loop RNA levels normalized to actin and calculated over the parental cells (individual experiments and mean, *n* = 2).\
Source data are available online for this figure.](EMBJ-36-981-g004){#embj201695335-fig-0002}

![Expression of Gal4‐MS2CP fusion proteins and luciferase activity in clones overexpressing *HOTAIR*\
Western blot analysis with Gal4 antibody on nuclear extracts from parental cell line (1) MS2BP, (2) MS2BP *MS2‐HOTAIR* (3) or MS2BP *MS2‐HOTAIR‐Rev* (4) and MS2 loop cell lines. SUZ12 was used as a loading control.qRT--PCR to detect MS2‐hybrid RNAs in the cell lines indicated on the *x*‐axis. *Y*‐axis represents MS2 loop RNA levels normalized to actin and calculated over the parental cells (mean ± SD, *n* = 2).Relative luciferase activity in the cell lines indicated on the *x*‐axis. Values represent the relative luciferase activity normalized to the amount of protein (mean ± SD, *n* = 3).Data information: Correspondence between numbers and model cell lines is indicated at the bottom right.Source data are available online for this figure.](EMBJ-36-981-g005){#embj201695335-fig-0002ev}

Having established the functionality of our system, we tested the transcriptional consequences of tethering *HOTAIR* RNA on the activity of the luciferase reporter. We observed a 75% reduction in luciferase activity in the presence of *MS2‐HOTAIR* RNA, a reduction that was not seen in the presence of *MS2‐HOTAIR‐Rev* RNA (Fig [2](#embj201695335-fig-0002){ref-type="fig"}D) or in cells overexpressing the MS2 loops alone (Fig [EV2](#embj201695335-fig-0002ev){ref-type="fig"}B). To verify that this effect was not clone specific and that it required continuous tethering of *MS2‐HOTAIR* RNA, we used three different strategies. First, we confirmed the repression of the luciferase reporter in another clone expressing equal levels of *MS2‐HOTAIR* (Fig [EV2](#embj201695335-fig-0002ev){ref-type="fig"}B and C). Then, we checked that *HOTAIR*‐mediated transcriptional repression is relieved when preventing its recruitment by knocking down the Gal4‐MS2BP protein. Indeed, upon effective knockdown of the Gal4‐MS2BP protein by RNA interference (shGAL4) in the MS2BP and MS2BP *MS2‐HOTAIR* cell models (Fig [2](#embj201695335-fig-0002){ref-type="fig"}E, lower panel), we observed a release of luciferase repression as compared to a scramble shRNA construct (Fig [2](#embj201695335-fig-0002){ref-type="fig"}E, upper panel). Finally, we verified that abrogating *HOTAIR* expression by knocking out the *MS2‐HOTAIR* construct in the MS2BP *MS2‐HOTAIR* cell model also releases luciferase repression. In two clones knocked out for the *MS2‐HOTAIR* construct as shown by qRT--PCR (Fig [2](#embj201695335-fig-0002){ref-type="fig"}F, lower panel, labeled 3‐*HOTAIR* K.O. cl.1 and 3‐*HOTAIR* K.O. cl.2), we could confirm a consistent increase in luciferase activity (Fig [2](#embj201695335-fig-0002){ref-type="fig"}F, upper panel).

Altogether, these results extensively validate our approach to tether RNA to chromatin. More importantly, we demonstrate that forced recruitment of *HOTAIR* specifically leads to transcriptional repression.

Artificial tethering of *HOTAIR* RNA is associated with changes in chromatin structure {#embj201695335-sec-0005}
--------------------------------------------------------------------------------------

Given the observed gene silencing effect of *HOTAIR* RNA, we wished to explore its underlying mechanisms and, in particular, whether it involves specific chromatin regulatory activities. Therefore, we performed ChIP experiments in our MS2‐*HOTAIR* RNA‐tethered system to evaluate H3K27me3 enrichment upon recruitment of *HOTAIR*. This assay revealed increased enrichment of H3K27me3 downstream of the 5× UAS (*LUC D* and *LUC E* primers) specifically in cells expressing MS2‐*HOTAIR* RNA (Fig [3](#embj201695335-fig-0003){ref-type="fig"}A). Importantly, not all repressive signatures were increased, since we did not observe any change when probing DNA methylation and H3K9me2 enrichment at the reporter transgene (Fig [EV3](#embj201695335-fig-0003ev){ref-type="fig"}B and C). Also, this effect required *HOTAIR* RNA recruitment as it was lost upon knockdown of the Gal4‐MS2BP protein (Fig [EV3](#embj201695335-fig-0003ev){ref-type="fig"}A). Of note, the gain of H3K27me3 in *MS2‐HOTAIR* cell line was relatively mild as compared to endogenous PRC2 target such as *MYT1* (Figs [3](#embj201695335-fig-0003){ref-type="fig"}A and [EV3](#embj201695335-fig-0003ev){ref-type="fig"}A). To determine whether other chromatin changes occur, we tested the enrichment of the H3K36me3 chromatin mark, which maps to the gene body of transcribed genes. In Gal4‐MS2BP and Gal4‐MS2BP *MS2‐HOTAIR‐Rev* cells, H3K36me3 levels in the gene body of the luciferase reporter (*LUC D* and *LUC E* primers) are 10 times lower than in the highly transcribed gene *ACT* (Fig [3](#embj201695335-fig-0003){ref-type="fig"}B). Nonetheless, we could detect a reduction in H3K36me3 enrichment in *MS2‐HOTAIR* cells (Fig [3](#embj201695335-fig-0003){ref-type="fig"}B). We observed similar trends when analyzing the enrichment for RNA polymerase II (Fig [EV3](#embj201695335-fig-0003ev){ref-type="fig"}B) but not for H3K27ac, which seems to have the same level of enrichment in all the model cell lines (Fig [EV3](#embj201695335-fig-0003ev){ref-type="fig"}B).

![*MS2‐HOTAIR* RNA modulates chromatin structure\
A, BChIP experiments with H3K27me3 (A) or H3K36me3 (B) antibody in the cell models numbered on the *x*‐axis of each graph; corresponding legend is at the bottom of the figure. Enrichment for primers located along the luciferase reporter (left) and enrichment for control regions (MYT1 and ACT) (right). *Y*‐axis represents percent of input (mean ± SD, *n* = 3 in A; individual experiments and mean, *n* = 2 in B). Statistical analysis: unpaired *t*‐test, \*\**P* \< 0.01.\
Source data are available online for this figure.](EMBJ-36-981-g006){#embj201695335-fig-0003}

![Chromatin regulation upon recruitment of *HOTAIR*\
ChIP experiments with H3K27me3 and primers located along the luciferase reporter (left) or control regions (MYT1 and ACT) (right) in the cell lines indicated on the *x*‐axis of each graph (individual experiments and mean, *n* = 2). A H3K27me3 antibody of different origin was used in this assay as compared to Fig [3](#embj201695335-fig-0003){ref-type="fig"}.ChIP experiments with H3K9me2 (top), H3K27ac (middle), or RNA polymerase II (bottom) in the cell lines indicated on the *x*‐axis of each graph. Primers used are indicated in the color legend (individual experiments and mean, *n* = 2).Analysis of DNA methylation. Schematic representation of the portion of the reporter construct analyzed for DNA methylation is displayed on top. It comprises the Gal4‐binding sites (5× UAS), the TK minimal promoter and part of the luciferase gene. DNA methylation analysis by bisulfite cloning is shown below in three different cell lines as indicated on the right. Black circles indicate methylated CpGs, and white circles indicate unmethylated CpGs. The percentage of methylated CpG is indicated below each condition.Data information: Correspondence between numbers and model cell lines is indicated at the bottom right.Source data are available online for this figure.](EMBJ-36-981-g007){#embj201695335-fig-0003ev}

We conclude from these experiments that *HOTAIR*‐mediated transcriptional repression correlates with mild losses and gains of a subset of active and repressive chromatin marks, respectively.

Gain of H3K27me3 upon tethering of *HOTAIR* RNA does not reflect a specific interaction between *HOTAIR* and PRC2 {#embj201695335-sec-0006}
-----------------------------------------------------------------------------------------------------------------

The results described above could fit with the hypothesis that *HOTAIR* RNA recruits PRC2 to chromatin. However, recent studies lead to contrasting conclusions regarding the specificity of PRC2 binding to RNA (Davidovich *et al*, [2013](#embj201695335-bib-0010){ref-type="ref"}; Kaneko *et al*, [2013](#embj201695335-bib-0018){ref-type="ref"}, [2014](#embj201695335-bib-0019){ref-type="ref"}; Beltran *et al*, [2016](#embj201695335-bib-0002){ref-type="ref"}). These discrepancies might be due in part to the control used to determine whether an interaction is specific. Having established that *HOTAIR‐Rev* transcript does not lead to an increased enrichment of H3K27me3 when tethered at a transgene, but considering that it is identical in size to *HOTAIR* transcript and that it is also predicted to form secondary structures, we reasoned that it represents an ideal control for interaction assays. We probed PRC2‐*HOTAIR* RNA interaction through two methods: first by sucrose density gradient and then by electrophoretic mobility shift assays (EMSA). We used highly purified PRC2 (Fig [EV4](#embj201695335-fig-0004ev){ref-type="fig"}A) and *in vitro* transcribed full‐length *HOTAIR* or *HOTAIR‐Rev* (Fig [EV4](#embj201695335-fig-0004ev){ref-type="fig"}B) for these assays. Results from the two approaches were mutually consistent and showed that PRC2 binds RNA with high affinity and little specificity; PRC2 interacts equally well with *HOTAIR* and *HOTAIR‐Rev* but displays a slightly higher affinity for MS2 loop RNA in EMSA (Fig [4](#embj201695335-fig-0004){ref-type="fig"}A and B). Next, we analyzed whether adding chromatin to the assay could impact the PRC2--*HOTAIR* interaction, as one might expect if *HOTAIR* acted as a bridge between PRC2 and chromatin. When we incubated chromatin with full‐length *HOTAIR* RNAs, the elution pattern of chromatin moved one fraction toward the RNA (Fig [EV4](#embj201695335-fig-0004ev){ref-type="fig"}C). This event is not specific, as both *HOTAIR* and *HOTAIR‐Rev* similarly affect the chromatin elution pattern. We then determined the effect of incubating all three partners together at an equimolar concentration: RNA, PRC2, and chromatin (Fig [EV4](#embj201695335-fig-0004ev){ref-type="fig"}D). We did not detect any obvious synergy between the three partners. Indeed, the elution pattern of PRC2 in the presence of *HOTAIR* and chromatin was similar to that observed with *HOTAIR* alone. Similarly, chromatin in the presence of *HOTAIR* and PRC2 shifts by one fraction as previously observed with *HOTAIR* alone. Of note, a recent report proposed that the interaction of PRC2 with RNA or chromatin is mutually exclusive, a conclusion which could be consistent with our observations (Beltran *et al*, [2016](#embj201695335-bib-0002){ref-type="ref"}).

![PRC2 and *HOTAIR in vitro* production\
Scheme for PRC2 production in Sf9 insect cells and purification over MiniQ column (left panel). Coomassie of eluted fractions. EZH2, SUZ12, EED‐FLAG and RbAp48 proteins are indicated (right panel).Agarose gel showing 2.2‐kb full‐length *in vitro* transcribed *HOTAIR* and *HOTAIR‐Rev* RNAs.Left: Scheme representing the interacting partners (chromatin and RNA) analyzed by sucrose gradient sedimentation on the right. Right: Native chromatin was incubated with or without biotinylated *HOTAIR/HOTAIR‐Rev* RNAs, and chromatin conformation was analyzed by density gradient centrifugation.Left: Scheme representing the interacting partners (chromatin, RNA and PRC2) analyzed by sucrose gradient on the right. Right: PRC2 and native chromatin were incubated with or without biotinylated *HOTAIR/HOTAIR‐Rev* RNAs and their profile analyzed by density gradient centrifugation.\
Source data are available online for this figure.](EMBJ-36-981-g009){#embj201695335-fig-0004ev}

![PRC2 interacts with RNA with low specificity\
PRC2 was incubated with or without biotinylated *HOTAIR* or *HOTAIR* reverse‐complement RNAs and analyzed by density gradient centrifugation on a linear sucrose gradient (10--30%). Individual fractions collected from sucrose gradient were probed by Western blot for EZH2 (upper panel) or by dot blot for biotinylated RNA (lower panel)**.**Representative EMSA experiments showing binding of PRC2 to full‐length *HOTAIR*,*HOTAIR‐Rev* and MS2 loop RNA probes. Equilibrium dissociation constant (*K* ~d~) values and Hill slope are calculated on biological replicates (*n* = 2). Corresponding binding curves of biological duplicate EMSA experiments (bottom panel).Predictive secondary structure for the first 530 bp of *HOTAIR* RNA from the RNAstructure software and VARNA visualization software. *HOTAIR* D1 domain as modeled by Somarowthu *et al* ([2015](#embj201695335-bib-0045){ref-type="ref"}) according to SHAPE‐CE probing is shown. SHAPE reactivities from Somarowthu *et al* ([2015](#embj201695335-bib-0045){ref-type="ref"}) are depicted by colored nucleotides; 1M7 SHAPE reactivity obtained in our experiment is represented by colored dots over the nucleotides. Highly reactive nucleotides are displayed in red and orange, and low reactive nucleotides are displayed in black or blue according to the values reported in the legend.EZH2 binds both *MS2‐HOTAIR* and *MS2‐HOTAIR‐Rev* RNAs *in vivo*. RIP experiments with EZH2 antibody in cell models indicated on the *x*‐axis. MS2 loop and U1 primers were used in qRT--PCR. *Y*‐axis represents relative enrichment (individual experiments and mean, *n* = 2). Input (In) and IP were loaded and probed with EZH2 antibody (lower panel). Correspondence between numbers and model cell lines is indicated at the bottom.\
Source data are available online for this figure.](EMBJ-36-981-g008){#embj201695335-fig-0004}

To exclude the possibility that the lack of specificity of PRC2 binding to RNA *in vitro* could be due to inappropriate folding of the RNA under our experimental settings, we probed *HOTAIR* RNA structure by SHAPE‐MaP (selective 2′‐hydroxyl acylation analyzed by primer extension) (Siegfried *et al*, [2014](#embj201695335-bib-0041){ref-type="ref"}; Smola *et al*, [2015](#embj201695335-bib-0044){ref-type="ref"}). Briefly, the RNA is incubated with small molecules that react with single‐stranded nucleotides, and high‐throughput sequencing is then used to identify the extent of mutations for each position. We used two different chemicals for this assay (NMIA and 1M7) and obtained SHAPE reactivity, which showed a good correlation between the two chemical probings as well as with the previously published data (see source data for Fig [4](#embj201695335-fig-0004){ref-type="fig"}C). We then focused on results obtained with 1M7 (Figs [4](#embj201695335-fig-0004){ref-type="fig"}C and [EV5](#embj201695335-fig-0005ev){ref-type="fig"}) for direct comparison with the previously published structure model of *HOTAIR* (Somarowthu *et al*, [2015](#embj201695335-bib-0045){ref-type="ref"}). Our reactivity map was used as constrains to model *HOTAIR* secondary structure using the software RNAstructure (Deigan *et al*, [2009](#embj201695335-bib-0011){ref-type="ref"}). The most stable secondary structure model predicted based on our 1M7 reactivities is slightly distinct from the previous report (Fig [EV5](#embj201695335-fig-0005ev){ref-type="fig"}); nonetheless, we observed a good overlap between the two structures as shown for the D1 domain (Fig [4](#embj201695335-fig-0004){ref-type="fig"}C). In summary, the consistency with Somarowthu\'s thorough *HOTAIR* structure probing makes us confident that *HOTAIR* RNA is folded in a similar structure in both studies.

![*HOTAIR* domain 1 secondary structure\
Secondary structure model for the first 530 bp of *HOTAIR* RNA obtained from the RNAstructure software using the 1M7 reactivity map obtained in this study and displayed with predictive secondary structure. *HOTAIR* D1 domain as mapped with 1M7 SHAPE probing from our experiment is shown. SHAPE reactivity is depicted by colored nucleotides. Highly reactive nucleotides are displayed in red and orange, and low reactive nucleotides are displayed in black or blue according to the values reported in the legend.Source data are available online for this figure.](EMBJ-36-981-g011){#embj201695335-fig-0005ev}

Finally, we determined whether our *in vitro* results hold true in a cellular context. To address this question, we performed RIP pulling down RNAs interacting with EZH2 in our different cell models. As expected, we observed that EZH2 RIP is enriched for *HOTAIR* over the IgG control. However, we obtained a similar enrichment for *HOTAIR*‐*Rev,* thus corroborating the *in vitro* findings (Fig [4](#embj201695335-fig-0004){ref-type="fig"}D). Although we cannot exclude the possibility that the MS2 loops interfere with *HOTAIR* structure in the artificial tethering assay, the similarity between our *in vitro* interaction experiments (*HOTAIR* without MS2 loops) and the RIP experiment in a cellular context (*HOTAIR* with MS2 loops) suggests that it is not the case.

Altogether, our experiments confirm the lack of specificity in the interaction of PRC2 with RNAs both *in vitro* and in cultured cells.

*HOTAIR*‐mediated transcriptional repression does not require PRC2 {#embj201695335-sec-0007}
------------------------------------------------------------------

A previous study reported that simply inhibiting transcription is sufficient to trigger the recruitment of PRC2 to many loci across the genome (Riising *et al*, [2014](#embj201695335-bib-0033){ref-type="ref"}). In light of those findings and the results of our interaction assays, we considered the possibility that the observed increased H3K27me3 enrichment subsequent to *HOTAIR* tethering might not be caused by direct *HOTAIR*‐mediated recruitment of PRC2, but might rather occur as a consequence of reduced transcription. To clarify this point, we employed CRISPR/Cas9 to knock out two essential PRC2 components (EED and SUZ12, Fig [5](#embj201695335-fig-0005){ref-type="fig"}A). Deleting either *EED* or *SUZ12* led to a complete loss of H3K27me3 both at the global level (Fig [5](#embj201695335-fig-0005){ref-type="fig"}A, top panel) and at the local level (Fig [5](#embj201695335-fig-0005){ref-type="fig"}B, lower panel). Yet, in two different *MS2‐HOTAIR*‐expressing subclones deleted for *EED* (cl.1 and cl.2) or *SUZ12* (cl.1 and cl.2) proteins, we observed the same transcriptional repression as in the *MS2‐HOTAIR* parental cell line with wild‐type PRC2 components (Fig [5](#embj201695335-fig-0005){ref-type="fig"}C).

![PRC2 is dispensable for *HOTAIR*‐mediated transcriptional repression\
Western blot analysis of nuclear extract from indicated cell lines with antibodies for SUZ12, EED and H3K27m2/3 mark. Lamin and H3 are shown as loading controls.ChIP experiments with IgG, histone H3, or H3K27me3 antibodies in the cell model indicated on top. Enrichment for the primers indicated on the right (individual experiments and mean, *n* = 2)Relative luciferase activity in the cell lines indicated on the *x*‐axis. Values represent the relative luciferase activity normalized to the amount of protein (individual experiments and mean, *n* = 2).Data information: Correspondence between numbers and model cell lines is indicated at the bottom right.Source data are available online for this figure.](EMBJ-36-981-g010){#embj201695335-fig-0005}

Altogether, our results demonstrate that the silencing of the luciferase reporter requires the continuous presence of *MS2‐HOTAIR* RNA but not H3K27me3 deposition. It suggests therefore that the *MS2‐HOTAIR* transcript modulates transcription independently of PRC2.

Discussion {#embj201695335-sec-0008}
==========

While an unexpected proportion of eukaryotic genomes is transcribed, many of the resulting transcripts are non‐coding RNAs. Among them, the subclass of lncRNAs has been implicated in the regulation of a variety of cellular functions. In particular, nuclear lncRNAs have been found to modulate transcription through the targeting of chromatin modifiers to specific genomic regions. One such example is *HOTAIR*, a lncRNA which was reported to promote breast cancers through the aberrant targeting of PRC2 and consequently inappropriate gene silencing (Gupta *et al*, [2010](#embj201695335-bib-0015){ref-type="ref"}). However, when we overexpressed *HOTAIR* RNA in MDA‐MB‐231 breast cancer cells, either in the presence or absence of PRC2, we detected few transcriptomic changes. While the reasons for the discrepancy with the previous report remain unclear, it underscores the need for caution when considering the potential contribution of *HOTAIR* transcript to tumorigenesis.

Considering the lack of broad *trans* effects of overexpressing *HOTAIR* RNA in MDA‐MB‐231 cell line, we sought a more direct way to gauge whether and how *HOTAIR* RNA regulates transcription. To address this question, we established cell models enabling to artificially tether *HOTAIR* RNA at a stably integrated reporter transgene. This approach revealed that, at least in this specific context and assuming that the MS2 loops do not interfere with *HOTAIR* structure, *HOTAIR* RNA can repress transcription. Several mechanisms could mediate this repressive activity. The most trivial model would be that *HOTAIR* RNA recruitment directly interferes with the RNA polymerase machinery, that is, by steric hindrance. Although we cannot formally exclude this hypothesis, it is undermined by the fact that the recruitment of the transcript antisense to *HOTAIR* (an RNA of identical size) did no impact on reporter activity. An alternative hypothesis is that *HOTAIR* recruits chromatin modifiers, which in turn modulate transcription. Accordingly, we observed that *HOTAIR* artificial recruitment is paralleled by mild changes in chromatin structure (histone methylation). However, when we deleted essential components of PRC2 that abrogate its methyltransferase activity, this did not affect the repressive activity of *HOTAIR* RNA. This shows that at least some of the major changes in chromatin composition upon recruitment of *HOTAIR* RNA are a secondary consequence of changes in transcription in our model. Last, *HOTAIR* may interfere with transcription by interacting with yet unknown factors. Unfortunately, our attempt to use yeast three‐hybrid system to identify such factors was unsuccessful (data not shown). Further investigation will therefore be required to address this point.

The interaction between PRC2 and RNA has retained a great deal of attention; however, different studies have reached contrasting conclusions (Davidovich *et al*, [2013](#embj201695335-bib-0010){ref-type="ref"}; Cifuentes‐Rojas *et al*, [2014](#embj201695335-bib-0008){ref-type="ref"}; Beltran *et al*, [2016](#embj201695335-bib-0002){ref-type="ref"}). Our results strongly support the weak specificity but strong affinity of PRC2 for RNAs (Davidovich *et al*, [2013](#embj201695335-bib-0010){ref-type="ref"}; Cifuentes‐Rojas *et al*, [2014](#embj201695335-bib-0008){ref-type="ref"}; Beltran *et al*, [2016](#embj201695335-bib-0002){ref-type="ref"}). The authors of the latest study proposed that chromatin and RNA might compete for binding to PRC2. In agreement with this idea, we did not find evidence for a complex between RNA, chromatin, and PRC2. We also observed that an excess of RNA could reduce PRC2 enzymatic activity on chromatin but not on another substrate, JARID2 (data not shown). This result is consistent with a specific competition between chromatin and RNA for interaction with PRC2. It is proposed that this antagonism could explain why active transcription prevents PRC2 recruitment (Beltran *et al*, [2016](#embj201695335-bib-0002){ref-type="ref"}). Intriguingly, the inhibitory activity of RNA on chromatin‐modifying enzymes is not exclusive to the PRC2, but appears to be a rather common property, since it has also been observed for SET9 (Kaneko *et al*, [2014](#embj201695335-bib-0019){ref-type="ref"}), G9A (data not shown), BRG1‐BAF (Cajigas *et al*, [2015](#embj201695335-bib-0004){ref-type="ref"}), and DNMT1 (Di Ruscio *et al*, [2013](#embj201695335-bib-0012){ref-type="ref"}), even though these enzymes have very distinct functions in transcriptional regulation. It is possible that the affinity of chromatin modifiers for RNA is important to compete with and therefore prevent low affinity and random binding to chromatin. Further studies will be required to test this hypothesis.

Materials and Methods {#embj201695335-sec-0009}
=====================

Recombinant proteins and PRC2 purification {#embj201695335-sec-0010}
------------------------------------------

hPRC2 production in SF9 insect cells was performed upon co‐infection with EZH2‐His, SUZ12‐His, RBBP4‐Strep‐TAG, and EED‐Flag‐tagged baculoviruses. Cells were lysed in BC300 buffer (300 mM KCl, 10% glycerol, 25 mM Tris--HCl pH 8, 1 mM EDTA), sonicated, and clarified by centrifugation before incubation with Flag beads (M2 beads SIGMA). PRC2 was eluted with Flag peptide and further purified on a MiniQ column to assure homogeneity and complete removal of nucleic acid contaminants. Fraction content was verified on Coomassie.

*In vitro* RNA transcription with biotinylated or radiolabeled UTP {#embj201695335-sec-0011}
------------------------------------------------------------------

One microgram of linearized pBluescript plasmid expressing *HOTAIR* reverse‐complement or MS2 loop RNA was *in vitro* transcribed for 3 h at 37°C using the MEGAscript T7 transcription kit (AM1334). After DNase treatment, when biotinylated, samples were purified over the MEGAclear™ transcription clean‐up kit (AM1908) and checked for full length on agarose gel. When radiolabeled, samples were cleaned with acid phenol/chloroform and precipitated at −20°C with 2.5 vol EtOH and 1/10 3 M NaAcet pH 5.3, 70% EtOH‐washed, and resuspended in DEPC H~2~O. RNAs were successively quantified by UV absorbance at 260 nm. Purity and integrity of all RNA batches were examined on a 0.8% agarose gel.

Refolding of *in vitro* transcribed RNA {#embj201695335-sec-0012}
---------------------------------------

*In vitro* transcribed RNA was heated at 95°C for 3 min, then immediately placed on ice for 2 min, added 2× refolding buffer (20 mM Tris pH 7; 200 mM KCl; 20 mM MgCl~2~), and refolded at RT for 20 min.

Nucleosome reconstitution {#embj201695335-sec-0013}
-------------------------

Nucleosomes were assembled from 5S 12 repeat DNA (Dorigo *et al*, [2004](#embj201695335-bib-0013){ref-type="ref"}) and purified HeLa cell histone octamers by salt dialysis through a linear gradient (2.2 M NaCl to 0.4 M NaCl) for 20 h, followed by a step dialysis against TE.

Sucrose gradient sedimentation analysis {#embj201695335-sec-0014}
---------------------------------------

Equimolar PRC2, *in vitro* reconstituted chromatin, and *in vitro* transcribed and refolded biotinylated RNAs were incubated together prior to sucrose gradients in HEB buffer (25 mM Hepes, 40 mM KCl, 0.2 mM EDTA, 1 mM DTT) for 1 h at RT.

Sucrose gradients were prepared using a gradient maker (Biocomp) according to the manufacturer\'s instruction and centrifuged for 16 h at 55,000 *g* in a Beckmann 60Ti rotor. Fractions were collected manually (250 μl each fraction), and 30 μl of each sample was loaded on NuPAGE Novex 4--12% Bis--Tris protein for Western blot analysis; 20 μl of each sample added with 0.5% SDS was loaded on 0.8% agarose gel, and 1 μl for each sample was spotted on positively charged nylon membrane nylon for dot blot.

Dot blot {#embj201695335-sec-0015}
--------

One micoliter from each sucrose gradient centrifugated fraction was spotted on positively charged nylon membrane, let dry for 30 min, and UV‐cross‐linked. RNA was revealed using the biotin chromogenic detection kit (KO661 Thermo Fischer Scientific) following the manual instructions.

Electrophoretic mobility shift assay {#embj201695335-sec-0016}
------------------------------------

Five nanomolar refolded RNA was incubated with increasing concentration of PRC2 in binding buffer (50 mM Tris--HCl, pH 7.5 at 25°C, 100 mM KCl, 5 mM MgCl~2~, 0.5 mM ZnCl~2~, 0.1 mM CaCl~2~, 2 mM 2‐mercaptoethanol, 0.1 mg/ml BSA, 0.1 mg/ml fragmented yeast tRNA, 5% v/v glycerol, 0.025% w/v bromophenol blue, and 0.025% w/v xylene cyanol) at 30°C for 30 min. Samples were cooled to 4°C for 10 min and loaded on a 0.7% agarose gel in 1× TBE buffer at 4°C. Gels were vacuum‐dried for 45 min at 80°C on a nylon membrane and two sheets of Whatman 3‐mm chromatography paper. Dried gels were exposed to phosphorimaging plates, and signal acquisition was performed with a Typhoon Trio phosphorimager (GE Healthcare). Densitometry was carried out with ImageJ software and data fitted to a sigmoidal binding curve with Prism Software. Data ranges for both dissociation constants and Hill coefficients were calculated on the basis of two replicates.

Cloning {#embj201695335-sec-0017}
-------

Construction of templates for *in vitro* transcription: *HOTAIR* cDNAs from LZRS‐HOTAIR (purchased from Addgene, plasmid \#26110, deposited by Howard Chang) were cloned into pBluescript plasmid digested with BamHI. pCR4‐24XMS2SL‐stable (Addgene plasmid \#31865, deposited by Robert Singer) was used to produce *in vitro* MS2 loop RNA. Fusion protein vector: pFLAG_NLS_MS2‐MS2 plasmid was a kind gift from Richard Breathnach (Gesnel *et al*, [2009](#embj201695335-bib-0014){ref-type="ref"}). Gal4‐DBD was cloned upstream MS2‐MS2 dimer coat protein with EcoRV/XbaI sites. MS2 loop‐RNA hybrid constructs: The MS2 loop repeat fragment was digested BamHI/BglII from pCR4‐24XMS2SL‐stable and inserted in the modified mammalian expression vector pCDNA4/TO linearized with BamHI restriction enzyme. To this plasmid, *HOTAIR* cDNA, digested BamHI from LZRS‐*HOTAIR* was ligated 5′ to the MS2 loop repeats. Both orientations were checked by restriction enzyme digestion and sequencing. Cloning the shGal4 sequence into the pLKO.1 hygro vector (Addgene plasmid \#24150, deposited by Bob Weinberg) was performed according to the pKLO‐TRC cloning vector procedure at <http://www.addgene.org/tools/protocols/plko/>. The target sequence for Gal4 was ATCGAACAAGCATGCGATATT.

The deletion cassette for *HOTAIR* was built by compatible restriction enzyme digestion and ligation and verified both by restriction enzyme digestion and sequencing at all steps. Briefly, 500 bp was amplified from the pCDNA4/TO HOTAIR‐MS2 loop plasmid comprising the promoter region and ligated to the hygromycin B resistance cassette followed by 640 bp of *HOTAIR* cDNA fragment, located 300 bp downstream the J. Rinn *HOTAIR* start site in a pBluescript plasmid. The gRNA target site, designed using the <http://crispor.tefor.net/> Web site, GAGAGCACCTCCGGGATATT was comprised within the first 300 bp of *HOTAIR* cDNA and cloned into the gRNA vector (Addgene plasmid \#41824, deposited by George Church) according to the Addgene procedure.

The deletion cassette for hEED was built cloning hygromycin B resistance cassette between left and right region homologs to EED exon 2. The gRNA target site GCACCTGGAAGGAAAAGTTG was cloned into the gRNA vector according to the Addgene procedure. The deletion cassette for hSUZ12 was done as for EED with left and right arm homologs to SUZ12 exon 10. The gRNA target site GAGACTCTCTGAATTTCTAG was cloned into the gRNA vector according to the Addgene procedure.

Cell culture and transfections {#embj201695335-sec-0018}
------------------------------

T‐Rex 293 cells (Invitrogen) were grown according to the manufacturer\'s instructions. MDA‐MB‐231‐derived cell lines were previously described (Wassef *et al*, [2015](#embj201695335-bib-0048){ref-type="ref"}). All cell lines were tested for the absence of mycoplasma on a monthly basis. All transfections were performed using PEI (polyethylenimine) at 3:1 ratio to DNA.

First, 5XGal4RE‐tk‐Luc‐Neo plasmid was stably integrated into the cells and selected for G418 resistance (0.5 μg/ml). One highly expressing luciferase clone was stably transfected and selected for pFLAG_Gal4DBD_NLS_MS2‐MS2 bearing puromycin resistance (10 μg/ml). Subsequently a single clone verified by Western blot for the expression of the fused Gal4DBD_NLS_MS2‐MS2 protein was transfected with each MS2 loop‐RNA hybrid plasmid bearing Zeocin resistance. Resistant clones selected for Zeocin (0.4 μg/ml) were tested for expression of the different MS2 loop‐RNA hybrid constructs by strand‐specific RT--PCR and qRT--PCR.

Co‐transfection with gRNA targeting *HOTAIR*, hCas9, and the targeted *HOTAIR* construct was performed with PEI. Hygromycin B selection was performed at 0.3 μg/ml.

Co‐transfections with gRNAs targeting EED or SUZ12, hCas9, and each of the EED and SUZ12 targeted constructs were performed with PEI. Hygromycin B selection was performed at 0.3 μg/ml.

Retroviral vector production and transduction {#embj201695335-sec-0019}
---------------------------------------------

Production of shGal4 lentiviral vector was performed in 293T cells. Transduction and selection of target cells were performed according to the online Addgene procedure. Hygromycin B was added at 0.3 μg/ml. Production of overexpressing *HOTAIR* retroviral vectors was performed in 293T cells. Transduction of target cells was performed as for the lentiviral vector.

Quantification of mRNA levels by qRT--PCR {#embj201695335-sec-0020}
-----------------------------------------

Total RNA was isolated following TRIzol reagent (Invitrogen) extraction instructions. cDNA was synthetized using SuperScript III reverse transcriptase kit (18080044 Invitrogen), and quantitative PCR was performed with technical triplicate using SYBR green reagent (Roche) on a ViiA7 equipment (Applied Biosystems). At least three biological independent experiments were performed for each assay.

Luciferase assay {#embj201695335-sec-0021}
----------------

Luciferase reporter activities were measured in whole‐cell lysates using the Luciferase Assay System (Promega, \#E15020) and Fluostar Optima BMG Labtech luminometer. All experiments were done in triplicate and normalized for protein concentration (Bradford).

Chromatin immunoprecipitation {#embj201695335-sec-0022}
-----------------------------

ChIPs were performed as previously described (Sanulli *et al*, [2015](#embj201695335-bib-0038){ref-type="ref"}). 1.2 × 10^7^ cells were plated in 15‐cm plates 2 days before cross‐linking. Quantification was done as previously described for the qRT--PCR. Primers sequences and antibodies used are provided in [Appendix Tables S2 and S3](#embj201695335-sup-0001){ref-type="supplementary-material"}.

DNA methylation analysis {#embj201695335-sec-0023}
------------------------

Genomic DNA was treated with bisulfite using EpiTect Bisulfite Kit (Qiagen) and PCR‐amplified using a nested PCR strategy. The PCR products were cloned using New England Biolab PCR cloning kit, and individual clones were analyzed by Sanger sequencing. DNA methylation analysis was performed using Quma (Kumaki *et al*, [2008](#embj201695335-bib-0025){ref-type="ref"}) (<http://quma.cdb.riken.jp/>).

RNA immunoprecipitation {#embj201695335-sec-0024}
-----------------------

RNA immunoprecipitation experiments were performed as previously described (Rinn *et al*, [2007](#embj201695335-bib-0034){ref-type="ref"}) with the following modifications. Two 15‐cm plates with 1.5 × 10^7^ cells each were plated 2 days before the experiment, a pre‐clearing step for 1--2 h at 4°C before the IP was performed with ON blocked beads (BSA 10 mg/ml as 100× and salmon sperm 10 mg/ml as 10×) in PBS or RIP buffer (150 mM KCl, 25 mM Tris pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5% NP‐40 added with protease inhibitors, PMSF, and RNase inhibitors). One‐fourth of the immunoprecipitated material was tested in Western blot analysis, and the rest was resuspended in TRIzol. Co‐precipitated RNAs were isolated, and qRT--PCR for MS2 loop RNA and U1 RNA was performed as described above. Primer sequences and antibodies used are provided in [Appendix Tables S2 and S3](#embj201695335-sup-0001){ref-type="supplementary-material"}.

RNA‐seq analysis {#embj201695335-sec-0025}
----------------

Total RNA from MDA‐MB‐231 cell lines was isolated by TRIzol extraction and quality‐verified by Bionalyzer. Isolated RNA was used to prepare cDNA libraries and amplified with primers containing sequences required for the Illumina platform. PCR products were cleaned and subjected to 100‐bp paired‐end sequencing on an Illumina Hi‐seq 2500. Sequenced reads from duplicate samples were assembled on the human genome hg19, using tophat_2.0.6 (Kim *et al*, [2013](#embj201695335-bib-0021){ref-type="ref"}).

The Htseq software (v0.6.0.) was used to define the number of reads associated with each gene. TMM normalization from the edgeR package v3.6.2 (Robinson & Oshlack, [2010](#embj201695335-bib-0035){ref-type="ref"}) was first applied. As described in the guideline of limma R package v3.20.4, normalized counts were processed by the voom method (Law *et al*, [2014](#embj201695335-bib-0026){ref-type="ref"}) to convert them into log~2~ counts per million with associated precision weights. The differential expression was estimated with the limma package. The *P*‐values were adjusted for multiple testing using the Benjamini--Hochberg procedure. Finally, differentially expressed genes with a log fold change \> 1, FPKM \> 1, and adjusted *P*‐value \< 0.05 were used for downstream analysis. Genes\' FPKM was estimated using the Cuffquant and Cuffnorm tools of the Cufflinks suite (v2.2.1).

The hierarchical clustering was performed using a Pearson correlation distance and a Ward linkage (R v3.2.0, hclust function).

Baculoviruses production {#embj201695335-sec-0026}
------------------------

RBBP4‐Strep‐TAG baculovirus was produced according to the Bac‐to‐Bac Baculovirus Expression Systems (Invitrogen) starting from pFASTbac vectors.

SHAPE‐MaP {#embj201695335-sec-0027}
---------

SHAPE‐MaP structure probing was performed as described by Smola *et al* ([2015](#embj201695335-bib-0044){ref-type="ref"}). Refolded RNA was incubated with 10 mM 1M7(+) (1‐methyl‐7‐nitroisatoic anhydride), 10 mM NMIA (+) (*N*‐methylisatoic anhydride) or an equal amount of pure DMSO as a control (−) for 3 min or 22 min at 37°C, respectively, due to the different half‐lives of the SHAPE reagents. The samples were then purified by G50 columns and subsequently fragmented to obtain 300‐bp RNA fragments. Reverse transcription was then performed in the presence of Mn^2+^ using SuperScript III reverse transcriptase kit (Invitrogen); finally, samples (+) and (−) were purified using G50 columns. In parallel, an RNA‐denatured sample was treated following the same steps as the (+) samples as a second negative control (−). SHAPE reactions (+) and (−) were then sequenced using an Ion Torrent sequencing platform, and sequencing data were taken into a bioinformatics pipeline to obtain SHAPE reactivities for 1M7 or NMIA for each RNA nucleotide and normalized for DMSO negative control and RNA‐denatured negative control. The bioinformatics script provided by the Weeks laboratory was adapted for Ion Torrent output files by A. Saadi and Y. Ponty (manuscript in preparation).

To generate the *HOTAIR* secondary structure maps using the software RNAstructure, SHAPE 1M7 reactivity was used to provide pseudo‐energy constraints, while VARNA software was used to visualize the predicted structure (Darty *et al*, [2009](#embj201695335-bib-0009){ref-type="ref"}). Resulting structures were manually evaluated for match with NMIA probing data. SHAPE reactivities are listed in the source data for Fig [4](#embj201695335-fig-0004){ref-type="fig"}C.

Nuclear extract {#embj201695335-sec-0028}
---------------

For nuclear extract preparation, cells were incubated with buffer A (10 mM Hepes pH 7.9, 2.5 mM MgCl~2~, 0.25 M sucrose, 0.1% NP‐40, 0.5 mM DTT, 1 mM PSMF) for 10 min on ice, centrifuged at 7,000 *g* for 10 min, resuspended in buffer B (25 mM Hepes pH 7.9, 1.5 mM MgCl~2~, 700 mM NaCl, 0.5 mM DTT, 0.1 mM EDTA, 20% glycerol), sonicated, and centrifuged at 21,000 *g* for 15 min.

Data access {#embj201695335-sec-0029}
-----------

The data discussed in this publication have been deposited in NCBI\'s Gene Expression Omnibus and are accessible through GEO series accession number GSE72524 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72524>).
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